✦ LIBER ✦

Novel therapeutic agents: A study to assess the maximum tolerated dose of tiagabine in patients with painful diabetic polyneuropathy

✍ Scribed by L. Kirby; B. Belleau

Book ID: 119305916
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 47 KB
Volume: 5
Category: Article
ISSN: 1528-8447
DOI: 10.1016/j.jpain.2004.02.207

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Active- and placebo-controlled dose-find

Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus

✍ Fonseca, Vivian A.; Ferrannini, Ele; Wilding, John P.; Wilpshaar, Wim; Dhanjal, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 222 KB

A multicenter open-label phase I/II stud

A multicenter open-label phase I/II study to assess the safety, tolerability, and efficacy of three dose levels of TuNEX in patients with rheumatoid arthritis

✍ Der-Yuan Chen; Ning-Sheng Lai; Ling-Ying Lu; Hsiu-Cheng Chou; Yi-Hsing Chen; Tsu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 Chinese ⚖ 428 KB

A Novel 12-Week Study, with Three Random

A Novel 12-Week Study, with Three Randomized, Double-Blind Placebo-Controlled Periods to Evaluate Fentanyl Buccal Tablets for the Relief of Breakthrough Pain in Opioid-Tolerant Patients with Noncancer-Related Chronic Pain

✍ John T. Farrar; John Messina; Fang Xie; Russell K. Portenoy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 737 KB

A placebo-controlled, double-blind, dose

A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock

✍ Peter E Morris; Brian Zeno; Andrew C Bernard; Xiangning Huang; Shampa Das; Timi 📂 Article 📅 2012 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 300 KB

234 A phase 1, open-label, dose-finding

234 A phase 1, open-label, dose-finding study to assess the safety and tolerability of U3 1287 (AMG 888), a human monoclonal antibody targeting HER3 in patients with advanced solid tumors

✍ P. LoRusso; V. Keedy; L. Yee; M. Oliveira; N. Rizvi; J. Berlin; X. Jin; T. Hettm 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Trends in sun exposure knowledge, attitu

Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996",June K. Robinson; Darrell S. Rigel; Rex A. Amonette 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80119-3,CME examination," 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80118-1,Antimicrobial agents for the dermatologist. I. β-Lactam antibiotics and related compounds,Marcia E. Epstein; Maria Amodio-Groton; Neil S. Sadick 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80140-5,Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis,P. Kullavanijaya; S. Reangchainam; R. Ungpakorn 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80143-0,Effect of topical pramoxine on experimentally induced pruritus in humans,Gil Yosipovitch; Howard I. Maibach 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80149-1,Treatment of psoriasis with the pulsed dye laser,S.W. Lanigan; G.A. Katugampola 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80147-8,Response rates in photopheresis therapy for cutaneous T-cell lymphoma,Herschel S. Zackheim; Mohammed Kashani-Sabet 01909622,37,1997,2-part-P1,10.1016/s0190-9622(97)80136-3,Keratosis lichenoides chronica: Response to topical calcipotriol,Marcelo H. Grunwald; Dafna Hallel-Halevy; Boaz Amichai 01909622,37,1997,1,10.1016/s0190-9622(97)70209-3,Relation between expression of adhesion molecules and clinical behavior in cutaneous follicle center cell lymphomas,Rob C. Beljaards; Peter Van Beek; Rein Willemze 01909622,37,1997,1,10.1016/s0190-9622(97)70208-1,A novel nonepidermolytic palmoplantar keratoderma: A clinical and histopathologic study of six cases,Cynthia M. Magro; Lynn A. Baden; Arthur N. Crowson; Paul E. Bowden; Howard P. Baden 01909622,37,1997,1,10.1016/s0190-9622(97)70216-0,"Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect

✍ Gerald D. Weinstein; Gerald G. Krueger; Nicholas J. Lowe; Madeleine Duvic; David 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 765 KB